Emerging role of cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions

Pharmacology and Therapeutics

Volumn 125, Issue 1, 2010, Pages 62-78

  Fornai, Matteo ^a   Antonioli, Luca ^a   Colucci, Rocchina ^a   Bernardini, Nunzia ^a   Ghisu, Narcisa ^a   Tuccori, Marco ^a   De Giorgio, Roberto ^b   Del Tacca, Mario ^a   Blandizzi, Corrado ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cyclooxygenase isoforms; Enteric nervous system; Gastrointestinal motility; Intestinal inflammation; Postoperative ileus

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; 5 BROMO 2 (4 FLUOROPHENYL) 3 (4 METHYLSULFONYLPHENYL)THIOPHENE; ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; DUP 398; ETODOLAC; FLURBIPROFEN; GR 253035X; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NIMESULIDE; NS 697; PARECOXIB; PIROXICAM; PLACEBO; PROSTAGLANDIN SYNTHASE; RESVERATROL; ROFECOXIB; UNCLASSIFIED DRUG; VALDECOXIB;

CLINICAL TRIAL; CONSTIPATION; DIABETES MELLITUS; DIGESTIVE SYSTEM FUNCTION DISORDER; DYSPEPSIA; ENTERITIS; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LOCALIZATION; ENZYME REGULATION; GASTROENTERITIS; GASTROESOPHAGEAL REFLUX; HUMAN; ILEUS; INTESTINAL DYSMOTILITY; INTESTINE MOTILITY; INTESTINE MUCOSA; LOWER ESOPHAGUS SPHINCTER; NEUROMUSCULAR FUNCTION; NONHUMAN; PATHOPHYSIOLOGY; PERITONITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEPTIC SHOCK; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; STOMACH EMPTYING; STOMACH INNERVATION; STOMACH PARESIS;

ANIMALS; CYCLOOXYGENASE INHIBITORS; ENTERIC NERVOUS SYSTEM; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HUMANS; ISOENZYMES; MUCOUS MEMBRANE; MUSCLE, SMOOTH; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 72049084490     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2009.09.007     Document Type: Review

References (189)

1. Anitha M., Gondha C., Sutliff R., Parsadanian A., Mwangi S., Sitaraman S.V., et al. GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway. J Clin Invest 116 (2006) 344-356
2. Antonioli L., Fornai M., Colucci R., Ghisu N., Tuccori M., Del Tacca M., et al. Regulation of enteric functions by adenosine: pathophysiological and pharmacological implications. Pharmacol Ther 120 (2008) 233-253
3. Akiho H., Deng Y., Blennerhassett P., Kanbayashi H., and Collins S.M. Mechanisms underlying the maintenance of muscle hypercontractility in a model of postinfective gut dysfunction. Gastroenterology 129 (2005) 131-141
4. Atay S., Tarnawski A.S., and Dubois A. Eicosanoids and the stomach. Prostaglandins Other Lipid Mediat 61 (2000) 105-124
5. Aube A.C., Cherbut C., Barbier M., Xing J.H., Roze C., and Galmiche J.P. Altered myoelectrical activity in noninflamed ileum of rats with colitis induced by trinitrobenzene sulphonic acid. Neurogastroenterol Motil 11 (1999) 55-62
6. Aulí M., Nasser Y., Ho W., Burgueño J.F., Keenan C.M., Romero C., et al. Neuromuscular changes in a rat model of colitis. Auton Neurosci 141 (2008) 10-21
7. 2 modulates neurally induced nonadrenergic, noncholinergic gastric relaxations in the rabbit in vivo. Gastroenterology 110 (1996) 129-138
8. Baker R.R. The eicosanoids: a historical overview. Clin Biochem 23 (1990) 455-458
9. Barbara G., Vallance B.A., and Collins S.M. Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice. Gastroenterology 113 (1997) 1224-1232
10. Barbara G., De Giorgio R., Deng Y., Vallance B., Blennerhassett P., and Collins S.M. Role of immunologic factors and cyclooxygenase 2 in persistent postinfective enteric muscle dysfunction in mice. Gastroenterology 120 (2001) 1729-1736
11. Barbara G., Cremon C., Pallotti F., De Giorgio R., Stanghellini V., and Corinaldesi R. Postinfectious irritable bowel syndrome. J Pediatr Gastroenterol Nutr 48 (2009) S95-S97
12. Bassotti G., and Villanacci V. Slow transit constipation: a functional disorder becomes an enteric neuropathy. World J Gastroenterol 12 (2006) 4609-4613
13. Bassotti G., Bucaneve G., Furno P., Morelli A., and Del Favero A. Double-blind, placebo-controlled study on effects of diclofenac sodium and indomethacin on postprandial gastric motility in man. Dig Dis Sci 43 (1998) 1172-1176
14. Baugmart D.C., and Carding R.R. Inflammatory bowel disease: cause and immunobiology. Lancet 369 (2007) 1627-1640
15. Benarroch E.E. Enteric nervous system: functional organization and neurologic implications. Neurology 69 (2007) 1953-1957
16. 2 in the human stomach, and a study of its effect on human isolated gastric muscle. Br J Pharmac Chemother 32 (1968) 339-349
17. Bennett A., Eley K.G., and Stockley H.L. Inhibition of peristalsis in guinea-pig isolated ileum and colon by drugs that block prostaglandin synthesis. Br J Pharmacol 57 (1976) 335-340
18. Bergin A.J., Donnelly T.C., McKendrick M.W., and Read N.W. Changes in anorectal function in persistent bowel disturbance following salmonella gastroenteritis. Eur J Gastroenterol Hepatol 5 (1993) 617-620
19. Bernardini N., Colucci R., Mattii L., Segnani C., Fornai M., De Giorgio R., et al. Constitutive expression of cyclooxygenase-2 in the neuromuscular compartment of normal human colon. Neurogastroenterol Motil 18 (2006) 654-656
20. Blandizzi C. Enteric alpha-2 adrenoceptors: pathophysiological implications in functional and inflammatory bowel disorders. Neurochem Int 51 (2007) 282-288
21. Blandizzi C., Fornai M., Colucci R., Baschiera F., Barbara G., De Giorgio R., et al. Altered prejunctional modulation of intestinal cholinergic and noradrenergic pathways by alpha2-adrenoceptors in the presence of experimental colitis. Br J Pharmacol 139 (2003) 309-320
22. Bouras E.P., Burton D.D., Camilleri M., Stephens D.A., and Thomforde G.M. Effect of cyclooxygenase-2 inhibitors on gastric emptying and small intestinal transit in humans. Neurogastroenterol Motil 16 (2004) 729-735
23. Breyer M.D., and Breyer R.M. G protein-coupled prostanoid receptors and the kidney. Annu Rev Physiol 63 (2001) 579-605
24. Brideau C., Kargman S., Liu S., Dallob A.L., Ehrich E.W., Rodger I.W., et al. A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors. Inflamm Res 45 (1996) 68-74
25. Burleigh D.E. The effects of indomethacin on the tone and spontaneous activity of the human small intestine in vitro. Arch Int Pharmacodyn Ther 225 (1977) 240-245
26. Cagossi M., Salgarello M., Patrignani P., and Salgarello G. Effects of various prostaglandin synthesis inhibitors on the tone of the lower oesophageal sphincter in man. Eur J Clin Pharmacol 43 (1992) 303-305
27. Calatayud S., García-Zaragozá E., Hernández C., Quintana E., Felipo V., Esplugues J.V., et al. Downregulation of nNOS and synthesis of PGs associated with endotoxin-induced delay in gastric emptying. Am J Physiol 283 (2002) G1360-G1367
28. Chadwick V.S., Chen W., Shu D., Paulus B., Bethwaite P., Tie A., et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 122 (2002) 1778-1783
29. Cheuk W., and Chan J.K. Subcellular localization of immunohistochemical signals: knowledge of the ultrastructural or biologic features of the antigens helps predict the signal localization and proper interpretation of immunostains. Int J Surg Pathol 12 (2004) 185-206
30. Coleski R., Gonlachanvit S., Owyang C., and Hasler W.L. Selective reversal of hyperglycemia-evoked gastric myoelectric dysrhythmias by nitrergic stimulation in healthy humans. J Pharmacol Exp Ther 312 (2005) 103-111
31. Collins S.M. The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology 111 (1996) 1683-1699
32. Cong P., Pricolo V., Biancani P., and Behar J. Abnormalities of prostaglandins and cyclooxygenase enzymes in female patients with slow-transit constipation. Gastroenterology 133 (2007) 445-453
33. Cook J.A. Eicosanoids. Crit Care Med 33 (2005) S488-S491
34. Corak A., Coşkun T., Alican I., Kurtel H., and Yeǧen B.C. The effect of nitric oxide synthase blockade and indomethacin on gastric emptying and gastric contractility. Pharmacology 54 (1997) 298-304
35. Cosme R., Lublin D., Takafuji V., Lynch K., and Roche J.K. Prostanoids in human colonic mucosa: effects of inflammation on PGE(2) receptor expression. Hum Immunol 61 (2000) 684-696
36. Costa M. COX and the gut: now we see it now we don't. Neurogastroenterol Motil 16 (2004) 693-695
37. Costa M., Brookes S.J., Steele P.A., Gibbins I., Burcher E., and Kandiah C.J. Neurochemical classification of myenteric neurons in the guinea-pig ileum. Neuroscience 75 (1996) 949-967
38. Cromlish W.A., and Kennedy B.P. Selective inhibition of cyclooxygenase-1 and -2 using intact insect cell assays. Biochem Pharmacol 52 (1996) 1777-1785
39. Day R., Morrison B., Luza A., Castaneda O., Strusberg A., Nahir M., et al. A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis. Rofecoxib/Ibuprofen Comparator Study Group. Arch Intern Med 160 (2000) 1781-1787
40. De Backer O., Leclere P.G., and Lefebvre R.A. Pharmacological characterization of pre- and postsynaptic prostanoid receptors in pig gastric fundus. Neuropharmacology 45 (2003) 684-690
41. De Filippis D., Iuvone T., Esposito G., Steardo L., Arnold G.H., Paul A.P., et al. Melatonin reverses lipopolysaccharide-induced gastro-intestinal motility disturbances through the inhibition of oxidative stress. J Pineal Res 44 (2008) 45-51
42. De Giorgio R., and Barbara G. Evidence for mast cell involvement in human postoperative ileus: a novel link. Gut 57 (2008) 5-7
43. De Giorgio R., Guerrini S., Barbara G., Stanghellini V., De Ponti F., Corinaldesi R., et al. Inflammatory neuropathies of the enteric nervous system. Gastroenterology 126 (2004) 1872-1883
44. de Godoy M.A., Rattan N., and Rattan S. COX-1 vs. COX-2 as a determinant of basal tone in the internal anal sphincter. Am J Physiol 296 (2009) G219-G225
45. de Godoy M.A., Rattan N., and Rattan S. Arachidonic acid metabolites follow the preferential course of cyclooxygenase pathway for the basal tone in the internal anal sphincter. Am J Physiol 296 (2009) G727-G734
46. De Jonge W.J., van den Wijngaard R.M., The F.O., ter Beek M.L., Bennink R.J., Tytgat G.N., et al. Postoperative ileus is maintained by intestinal immune infiltrates that activate inhibitory neural pathways in mice. Gastroenterology 125 (2003) 1137-1147
47. de la Fuente S.G., McMahon R.L., Clary E.M., Harris M.B., Lawson D.C., Reynolds J.D., et al. Celecoxib (celebrex) increases canine lower esophageal sphincter pressure. J Surg Res 107 (2002) 154-158
48. De Winter B.Y., Boeckxstaens G.E., De Man J.G., Moreels T.G., Herman A.G., and Pelckmans P.A. Effect of adrenergic and nitrergic blockade on experimental ileus in rats. Br J Pharmacol 120 (1997) 464-468
49. De Winter B.Y., van Nassauw L., de Man J.G., De Jonge F., Bredenoord A.J., Seerden T.C., et al. Role of oxidative stress in the pathogenesis of septic ileus in mice. Neurogastroenterol Motil 17 (2005) 251-261
50. Diaz B.L., and Arm J.P. Phospholipase A(2). Prostaglandins Leukot Essent Fatty Acids 69 (2003) 87-97
51. Di Nardo G., Blandizzi C., Volta U., Colucci R., Stanghellini V., Barbara G., et al. Review article: molecular, pathological and therapeutic features of human enteric neuropathies. Aliment Pharmacol Ther 28 (2008) 25-42
52. DuBois R.N. Cyclooxygenase-2 and colorectal cancer. Prog Exp Tumor Res 37 (2003) 124-137
53. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., De Putte V., et al. Cyclooxygenase in biology and disease. FASEB J 12 (1998) 1063-1073
54. Duncan M., Mouihate A., Mackie K., Keenan C.M., Buckley N.E., Davison J.S., et al. Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats. Am J Physiol 295 (2008) G78-G87
55. Eskandari M.K., Kalff J.C., Billiar T.R., Lee K.K., and Bauer A.J. Lipopolysaccharide activates the muscularis macrophage network and suppresses circular smooth muscle activity. Am J Physiol 273 (1997) G727-G734
56. Folwaczny C., Wawarta R., Otto B., Friedrich S., Landgraf R., and Riepl R.L. Gastric emptying of solid and liquid meals in healthy controls compared with long-term type-1 diabetes mellitus under optimal glucose control. Exp Clin Endocrinol Diabetes 111 (2003) 223-229
57. Fornai M., Blandizzi C., Colucci R., Antonioli L., Bernardini N., Segnani C., et al. Role of cyclooxygenases 1 and 2 in the modulation of neuromuscular functions in the distal colon of humans and mice. Gut 54 (2005) 608-616
58. Fornai M., Blandizzi C., Antonioli L., Colucci R., Bernardini N., Segnani C., et al. Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation. J Pharmacol Exp Ther 317 (2006) 938-945
59. Fujimoto Y., Uno E., and Sakuma S. Effects of reactive oxygen and nitrogen species on cyclooxygenase-1 and -2 activities. Prostaglandins Leukot Essent Fatty Acids 71 (2004) 335-340
60. Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294 (2001) 1871-1875
61. Furness J.B. The enteric nervous system: normal functions and enteric neuropathies. Neurogastroenterol Motil 20 (2008) 32-38
62. Garavito R.M., and Mulichak A.M. The structure of mammalian cyclooxygenases. Annu Rev Biophys Biomol Struct 32 (2003) 183-206
63. Garavito R.M., Malkowski M.G., and DeWitt D.L. The structures of prostaglandin endoperoxide H synthases-1 and -2. Prostaglandins Other Lipid Mediat 68-69 (2002) 129-152
64. Garewal H., Ramsey L., Fass R., Hart N.K., Payne C.M., Bernstein H., et al. Perils of immunohistochemistry: variability in staining specificity of commercially available COX-2 antibodies on human colon tissue. Dig Dis Sci 48 (2003) 197-202
65. Gierse J.K., Zhang Y., Hood W.F., Walker M.C., Trigg J.S., Maziasz T.J., et al. Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity. J Pharmacol Exp Ther 312 (2005) 1206-1212
66. Grasa L., Arruebo M.P., Plaza M.A., and Murillo M.D. A downregulation of nNOS is associated to dysmotility evoked by lipopolysaccharide in rabbit duodenum. J Physiol Pharmacol 59 (2008) 511-524
67. Harper K.A., and Tyson-Capper A.J. Complexity of COX-2 gene regulation. Biochem Soc Trans 36 (2008) 543-545
68. Hata A.N., and Breyer R.M. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol Ther 103 (2004) 147-166
69. Haworth R., Oakley K., McCormack N., and Pilling A. Differential expression of COX-1 and COX-2 in the gastrointestinal tract of the rat. Toxicol Pathol 33 (2005) 239-245
70. Holte K., and Kehlet H. Postoperative ileus: a preventable event. Br J Surg 87 (2000) 1480-1493
71. Hori M., Kita M., Torihashi S., Miyamoto S., Won K.J., Sato K., et al. Upregulation of iNOS by COX-2 in muscularis resident macrophage of rat intestine stimulated with LPS. Am J Physiol 280 (2001) G930-G938
72. Jackson L.M., Wu K.C., Mahida Y.R., Jenkins D., and Hawkey C.J. Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa. Gut 47 (2000) 762-770
73. Jean-Baptiste E. Cellular mechanisms in sepsis. J Intensive Care Med 22 (2007) 63-72
74. Josephs M.D., Cheng G., Ksontini R., Moldawer L.L., and Hocking M.P. Products of cyclooxygenase-2 catalysis regulate postoperative bowel motility. J Surg Res 86 (1999) 50-54
75. Jupp J., Hillier K., Elliott D.H., Fine D.R., Bateman A.C., Johnson P.A., et al. Colonic expression of leukotriene-pathway enzymes in inflammatory bowel diseases. Inflamm Bowel Dis 13 (2007) 537-546
76. Kalff J.C., Schraut W.H., Simmons R.L., and Bauer A.J. Surgical manipulation of the gut elicits an intestinal muscularis inflammatory response resulting in postsurgical ileus. Ann Surg 228 (1998) 652-663
77. Kalff J.C., Buchholz B.M., Eskandari M.K., Hierholzer C., Schraut W.H., Simmons R.L., et al. Biphasic response to gut manipulation and temporal correlation of cellular infiltrates and muscle dysfunction in rat. Surgery 126 (1999) 498-509
78. Kalff J.C., Türler A., Schwarz N.T., Schraut W.H., Lee K.K., Tweardy D.J., et al. Intra-abdominal activation of a local inflammatory response within the human muscularis externa during laparotomy. Ann Surg 237 (2003) 301-315
79. Kang S.S., Cuendet M., Endringer D.C., Croy V.L., Pezzuto J.M., and Lipton M.A. Synthesis and biological evaluation of a library of resveratrol analogues as inhibitors of COX-1, COX-2 and NF-kappaB. Bioorg Med Chem 17 (2009) 1044-1054
80. Kargman S., Charleson S., Cartwright M., Frank J., Riendeau D., Mancini J., et al. Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology 111 (1996) 445-454
81. Karmeli F., Cohen P., and Rachmilewitz D. Cyclo-oxygenase-2 inhibitors ameliorate the severity of experimental colitis in rats. Eur J Gastroenterol Hepatol 12 (2000) 223-231
82. Kaya T.T., Koyluoglu G., Soydan A.S., Arpacik M., and Karadas B. Effects of nimesulide and pentoxifylline on decreased contractile responses in rat ileum with peritonitis. Eur J Pharmacol 442 (2002) 147-153
83. Kerola M., Vuolteenaho K., Kosonen O., Kankaanranta H., Sarna S., and Moilanen E. Effects of nimesulide, acetylsalicylic acid, ibuprofen and nabumetone on cyclooxygenase-1- and cyclooxygenase-2-mediated prostanoid production in healthy volunteers ex vivo. Basic Clin Pharmacol Toxicol 104 (2009) 17-21
84. Kinoshita K., Horiguchi K., Fujisawa M., Kobirumaki F., Yamato S., Hori M., et al. Possible involvement of muscularis resident macrophages in impairment of interstitial cells of Cajal and myenteric nerve systems in rat models of TNBS-induced colitis. Histochem Cell Biol 127 (2007) 41-53
85. Koch T.R., Carney J.A., Go L., and Go V.L. Idiopathic chronic constipation is associated with decreased colonic vasoactive intestinal peptide. Gastroenterology 94 (1988) 300-310
86. Korolkiewicz R.P., Ujda M., Dabkowski J., Ruczyński J., Rekowski P., and Petrusewicz J. Differential salutary effects of nonselective and selective COX-2 inhibitors in postoperative ileus in rats. J Surg Res 109 (2003) 161-169
87. Koyluoglu G., Bagcivan I., Karadas B., Guney C., Durmus N., Altun A., et al. Alterations in spontaneous contractions of rat ileum and jejunum after peritonitis. Eur J Pharmacol 580 (2008) 250-255
88. Krauter E.M., Strong D.S., Brooks E.M., Linden D.R., Sharkey K.A., and Mawe G.M. Changes in colonic motility and the electrophysiological properties of myenteric neurons persist following recovery from trinitrobenzene sulfonic acid colitis in the guinea pig. Neurogastroenterol Motil 19 (2007) 990-1000
89. Kruschewski M., Anderson T., Buhr H.J., and Loddenkemper C. Selective COX-2 inhibition reduces leukocyte sticking and improves the microcirculation in TNBS colitis. Dig Dis Sci 51 (2006) 662-670
90. Kurumbail R., Stevens A., Girse J., McDonald J., Stegeman R., Pak J., et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 384 (1996) 644-648
91. Laine L., Takeuchi K., and Tarnawski A. Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology 135 (2008) 41-60
92. 2. World J Gastroenterol 11 (2005) 357-361
93. Lincoln J., Crowe R., Kamm M.A., Burnstock G., and Lennard-Jones J.E. Serotonin and 5-hydroxyindoleacetic acid are increased in the sigmoid colon in severe idiopathic constipation. Gastroenterology 98 (1990) 1219-1225
94. Linden D.R., Sharkey K.A., Ho W., and Mawe G.M. Cyclooxygenase-2 contributes to dysmotility and enhanced excitability of myenteric AH neurones in the inflamed guinea pig distal colon. J Physiol 557 (2004) 191-205
95. Liu L., Shang F., Morgan M.J., King D.W., Lubowski D.Z., and Burcher E. Cyclooxygenase-dependent alterations in substance P-mediated contractility and tachykinin NK1 receptor expression in the colonic circular muscle of patients with slow transit constipation. J Pharmacol Exp Ther 329 (2009) 282-289
96. 2 in guinea pig colonic myenteric ganglia. Am J Physiol 283 (2002) G1388-G1397
97. Martin G.R., and Wallace J.L. Gastrointestinal inflammation: a central component of mucosal defense and repair. Exp Biol Med 231 (2006) 130-137
98. Martín A.R., Villegas I., La Casa C., and Alarcón de la Lastra C. The cyclo-oxygenase-2 inhibitor, rofecoxib, attenuates mucosal damage due to colitis induced by trinitrobenzene sulphonic acid in rats. Eur J Pharmacol 481 (2003) 281-291
99. Martín A.R., Villegas I., and Alarcón de la Lastra C. The COX-2 inhibitor, rofecoxib, ameliorates dextran sulphate sodium induced colitis in mice. Inflamm Res 54 (2005) 145-151
100. Matuk R., Crawford J., Abreu M.T., Targan S.R., Vasiliauskas E.A., and Papadakis K.A. The spectrum of gastrointestinal toxicity and effect on disease activity of selective cyclooxygenase-2 inhibitors in patients with inflammatory bowel disease. Inflamm Bowel Dis 10 (2004) 352-356
101. Mazzone A., and Farrugia G. Evolving concepts in the cellular control of gastrointestinal motility: neurogastroenterology and enteric sciences. Gastroenterol Clin North Am 36 (2007) 499-513
102. Meile T., Glatzle J., Habermann F.M., Kreis M.E., and Zittel T.T. Nitric oxide synthase inhibition results in immediate postoperative recovery of gastric, small intestinal and colonic motility in awake rats. Int J Colorectal Dis 21 (2006) 121-129
103. Menozzi A., Pozzoli C., Poli E., Dacasto M., Giantin M., Lopparelli R.M., et al. Effects of nonselective and selective cyclooxygenase inhibitors on small intestinal motility in the horse. Res Vet Sci 86 (2009) 129-135
104. Miedema B.W., and Johnson J.O. Methods for decreasing postoperative gut dysmotility. Lancet Oncol 4 (2003) 365-372
105. Milenov K., and Golenhofen K. Contractile responses of longitudinal and circular smooth muscle of the canine stomach to prostaglandins E and F2alpha. Prostaglandins Leukot Med 8 (1982) 287-300
106. Milenov K., and Rakovska A. The role of prostaglandins in the spontaneous and cholinergic nerve-mediated motility of guinea-pig gastric muscle. Methods Find Exp Clin Pharmacol 5 (1983) 121-126
107. Mohajer B., and Ma T.Y. Eicosanoids and the small intestine. Prostaglandins Other Lipid Mediat 61 (2000) 125-143
108. Moreels T.G., De Man J.G., Dick J.M., Nieuwendijk R.J., De Winter B.Y., Lefebvre R.A., et al. Effect of TNBS-induced morphological changes on pharmacological contractility of the rat ileum. Eur J Pharmacol 423 (2001) 211-222
109. Müller-Decker K., Albert C., Lukanov T., Winde G., Marks F., and Fürstenberger G. Cellular localization of cyclo-oxygenase isozymes in Crohn's disease and colorectal cancer. Int J Colorectal Dis 14 (1999) 212-218
110. Nardone G., and Rocco A. Chemoprevention of gastric cancer: role of COX-2 inhibitors and other agents. Dig Dis 22 (2004) 320-326
111. Nathan C.F. Secretory products of macrophages. J Clin Invest 79 (1987) 319-326
112. Neuman M.G. Immune dysfunction in inflammatory bowel disease. Trans Res 149 (2006) 173-186
113. Neunlist M., Aubert P., Toquet C., Oreshkova T., Barouk J., Lehur P.A., et al. Changes in chemical coding of myenteric neurones in ulcerative colitis. Gut 52 (2003) 84-90
114. Neurath M., Fuss I., and Strober W. TNBS-colitis. Int Rev Immunol 19 (2000) 51-62
115. Nitta H., and Ishizawa M. Endogenous prostaglandins and spontaneous contractions in the circular muscle of the guinea-pig stomach. Jpn J Physiol 30 (1980) 815-826
116. 2 analog on gastric emptying and secretion in rhesus monkeys. J Pharmacol Exp Ther 212 (1980) 491-495
117. Northey A., Denis D., Cirino M., Metters K.M., and Nantel F. Cellular distribution of prostanoid EP receptors mRNA in the rat gastrointestinal tract. Prostagl other Lipid Mediat 62 (2000) 145-156
118. Nylander B., and Mattsson O. Effect of 16, 16-dimethyl PGE2 on gastric emptying and intestinal transit of a barium-food test meal in man. Scand J Gastroenterol 10 (1975) 289-292
119. Ohama T., Hori M., and Ozaki H. Mechanism of abnormal intestinal motility in inflammatory bowel disease: how smooth muscle contraction is reduced?. J Smooth Muscle Res 43 (2007) 43-54
120. Okayama M., Hayashi S., Aoi Y., Nishio H., Kato S., and Takeuchi K. Aggravation by selective COX-1 and COX-2 inhibitors of dextran sulfate sodium (DSS)-induced colon lesions in rats. Dig Dis Sci 52 (2007) 2095-2103
121. O'Neill G.P., and Ford-Hutchinson A.W. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett 330 (1993) 156-160
122. Patrono C., Patrignani P., and Garcia-Rodriguez L.A. Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs. J Clin Invest 108 (2001) 7-13
123. Peng H., Cheung A.K., Reimer L.G., Kamerath C.D., and Leypoldt J.K. Effect of indomethacin on peritoneal protein loss in a rabbit model of peritonitis. Kidney Int 59 (2001) 44-51
124. Peskar B.M. Neural aspects of prostaglandin involvement in gastric mucosal defense. J Physiol Pharmacol 52 (2001) 555-568
125. Peskar B.M. Role of cyclooxygenase isoforms in gastric mucosal defense and ulcer healing. Inflammopharmacology 13 (2005) 15-26
126. Peskar B.M., Maricic N., Gretzera B., Schuligoi R., and Schmassmann A. Role of cyclooxygenase-2 in gastric mucosal defense. Life Sci 69 (2001) 2993-3003
127. Pihl L., and Nylander O. Products of cyclooxygenase-2 depress duodenal function in rats subjected to abdominal surgery. Acta Physiol (Oxf) 186 (2006) 279-290
128. Podolsky D.K. Inflammatory bowel disease. N Engl J Med 347 (2002) 417-429
129. Porcher C., Horowitz B., Bayguinov O., Ward S.M., and Sanders K.M. Constitutive expression and function of cyclooxygenase-2 in murine gastric muscles. Gastroenterology 122 (2002) 1442-1454
130. Porcher C., Horowitz B., Ward S.M., and Sanders K.M. Constitutive and functional expression of cyclooxygenase 2 in the murine proximal colon. Neurogastroenterol Motil 16 (2004) 785-799
131. Prasad M., and Matthews J.B. Deflating postoperative ileus. Gastroenterology 117 (1999) 489-492
132. Rebollar E., Arruebo M.P., Plaza M.A., and Murillo M.D. Effect of lipopolysaccharide on rabbit small intestine muscle contractility in vitro: role of prostaglandins. Neurogastroenterol Motil 14 (2002) 633-642
133. Reddy S.N., Bazzocchi G., Chan S., Akashi K., Villanueva-Meyer J., Yanni G., et al. Colonic motility and transit in health and ulcerative colitis. Gastroenterology 101 (1991) 1289-1297
134. Riendeau D., Percival M.D., Boyce S., Brideau C., Charleson S., Cromlish W., et al. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol 121 (1997) 105-117
135. Robert A., Nezamis J.E., and Lancaster C. Effect of 16,16 dimethyl PGE2 on gastric emptying. In: Samuelsson B. (Ed). Advances in Prostaglandin and Thromboxane Research Vol. 2 (1976), Raven Press, New York 946
136. Roberts P.J., Morgan K., Miller R., Hunter J.O., and Middleton S.J. Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease. Gut 48 (2001) 468-472
137. Ruwart M.J., and Rush B.D. Prostacyclin inhibits gastric emptying and small-intestinal transit in rats and dogs. Gastroenterology 87 (1984) 392-395
138. Sanders K.M. Role of prostaglandins in regulating gastric motility. Am J Physiol 246 (1984) G361-G371
139. Santos C.L., Medeiros B.A., Palheta-Junior R.C., Macedo G.M., Nobre-e-Souza M.A., Troncon L.E., et al. Cyclooxygenase-2 inhibition increases gastric tone and delays gastric emptying in rats. Neurogastroenterol Motil 19 (2007) 225-232
140. Sato K., Torihashi S., Hori M., Nasu T., and Ozaki H. Phagocytotic activation of muscularis resident macrophages inhibits smooth muscle contraction in rat ileum. J Vet Med Sci 69 (2007) 1053-1060
141. Scheurer U., Drack E., and Halter F. Cyclooxygenase inhibitors affect Met-enkephalin- and acetylcholine-stimulated motility of the isolated rat colon. J Pharmacol Exp Ther 234 (1985) 742-746
142. Schvarcz E., Palmér M., Aman J., Horowitz M., Stridsberg M., and Berne C. Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus. Gastroenterology 113 (1997) 60-66
143. Schwarz N.T., Kalff J.C., Türler A., Engel B.M., Watkins S.C., Billiar T.R., et al. Prostanoid production via COX-2 as a causative mechanism of rodent postoperative ileus. Gastroenterology 121 (2001) 1354-1371
144. Schwarz N.T., Kalff J.C., Türler A., Speidel N., Grandis J.R., Billiar T.R., et al. Selective jejunal manipulation causes postoperative pan-enteric inflammation and dysmotility. Gastroenterology 126 (2004) 159-169
145. Shahbazian A., Schuligoi R., Heinemann A., Peskar B.A., and Holzer P. Disturbance of peristalsis in the guinea-pig isolated small intestine by indomethacin, but not cyclo-oxygenase isoform-selective inhibitors. Br J Pharmacol 132 (2001) 1299-1309
146. Sharkey K.A., and Kroese A.B. Consequences of intestinal inflammation on the enteric nervous system: neuronal activation induced by inflammatory mediators. Anat Rec 262 (2001) 79-90
147. Shea-Donohue P.T., Myers L., Castell D.O., and Dubois A. Effect of prostacyclin on gastric emptying and secretion in rhesus monkeys. Gastroenterology 78 (1980) 1476-1479
148. Shea-Donohue P.T., Nompleggi D., and Dubois A. Effect of a prostaglandin F2 analog on gastric emptying and secretion in rhesus monkeys. J Pharmacol Exp Ther 219 (1981) 287-289
149. Shea-Donohue T., Steel L., Montcalm-Mazzilli E., and Dubois A. Aspirin-induced changes in gastric function: role of endogenous prostaglandins and mucosal damage. Gastroenterology 98 (1990) 284-292
150. Sim R., Cheong D.M., Wong K.S., Lee B.M., and Liew Q.Y. Prospective randomized, double-blind, placebo-controlled study of pre- and postoperative administration of a COX-2-specific inhibitor as opioid-sparing analgesia in major colorectal surgery. Colorectal Dis 9 (2007) 52-60
151. Sjölund K., Fasth S., Ekman R., Hultén L., Jiborn H., Nordgren S., et al. Neuropeptides in idiopathic chronic constipation (slow transit constipation). Neurogastroenterol Motil 9 (1997) 143-150
152. Smid S.D., and Svensson K.M. Inhibition of cyclooxygenase-2 and EP(1) receptor antagonism reduces human colonic longitudinal muscle contractility in vitro. Prostaglandins Other Lipid Mediat 88 (2009) 117-121
153. Smith W.L. Nutritionally essential fatty acids and biologically indispensable cyclooxygenases. Trends Biochem Sci 33 (2008) 27-37
154. Smith J.L., and Bayles D. Postinfectious irritable bowel syndrome: a long-term consequence of bacterial gastroenteritis. J Food Prot 70 (2007) 1762-1769
155. Smith W.L., Garavito R.M., and DeWitt D.L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271 (1996) 33157-33160
156. Smith C.J., Zhang Y., Koboldt C.M., Muhammad J., Zweifel B.S., Shaffer A., et al. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci USA 95 (1998) 13313-13318
157. Smith W.L., DeWitt D.L., and Garavito R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69 (2000) 145-182
158. Souza M.H., Troncon L.E., Cunha F.Q., and Oliveira R.B. Decreased gastric tone and delayed gastric emptying precede neutrophil infiltration and mucosal lesion formation in indomethacin induced gastric damage in rats. Braz J Med Biol Res 36 (2003) 1383-1390
159. Spiller R.C. Postinfectious irritable bowel syndrome. Gastroenterology 124 (2003) 1662-1671
160. Stein J., Zeuzem S., Uphoff K., and Laube H. Effects of prostaglandins and indomethacin on gastric emptying in the rat. Prostaglandins 47 (1994) 31-40
161. Subbaramaiah K., and Dannenberg A.J. Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol Sci 24 (2003) 96-102
162. Tacconelli S., Capone M.L., Sciulli M.G., Ricciotti E., and Patrignani P. The selectivity of novel COX-2 inhibitors in human whole blood assays of COX-isozyme activity. Curr Med Res Opin 18 (2002) 503-511
163. Taché Y., Mönnikes H., Bonaz B., and Rivier J. Role of CRF in stress-related alterations of gastric and colonic motor function. Ann N Y Acad Sci 697 (1993) 233-243
164. Tanabe T., and Tohnai N. Cyclooxygenase isozymes and their gene structures and expression. Prostaglandins Other Lipid Mediat 68-69 (2002) 95-114
165. Tanaka S., Tatsuguchi A., Futagami S., Gudis K., Wada K., Seo T., et al. Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma. Gut 55 (2006) 54-61
166. Thor P., Konturek J.W., Konturek S.J., and Anderson J.H. Role of prostaglandins in control of intestinal motility. Am J Physiol 248 (1985) G353-G359
167. Tjwa E.T., Bradley J.M., Keenan C.M., Kroese A.B., and Sharkey K.A. Interleukin-1beta activates specific populations of enteric neurons and enteric glia in the guinea pig ileum and colon. Am J Physiol 285 (2003) G1268-G1276
168. To K.F., Chan F.K., Cheng A.S., Lee T.L., Ng Y.P., and Sung J.J. Up-regulation of cyclooxygenase-1 and -2 in human gastric ulcer. Aliment Pharmacol Ther 15 (2001) 25-34
169. Tsubouchi R., Hayashi S., Aoi Y., Nishio H., Terashima S., Kato S., et al. Healing impairment effect of cyclooxygenase inhibitors on dextran sulphate sodium-induced colitis in rats. Digestion 74 (2006) 91-100
170. Türler A., Moore B.A., Pezzone M.A., Overhaus M., Kalff J.C., and Bauer A.J. Colonic postoperative inflammatory ileus in the rat. Ann Surg 236 (2002) 56-66
171. Tzavella K., Riepl R.L., Klauser A.G., Voderholzer W.A., Schindlbeck N.E., and Müller-Lissner S.A. Decreased substance P levels in rectal biopsies from patients with slow transit constipation. Eur J Gastroenterol Hepatol 8 (1996) 1207-1211
172. Vane J.R., Bakhle Y.S., and Botting R.M. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38 (1998) 97-120
173. van der Woude C.J., Moshage H., Homan M., Kleibeuker J.H., Jansen P.L., and van Dekken H. Expression of apoptosis related proteins during malignant progression in chronic ulcerative colitis. J Clin Pathol 58 (2005) 811-814
174. van Till J.W., van Veen S.Q., van Ruler O., Lamme B., Gouma D.J., and Boermeester M.A. The innate immune response to secondary peritonitis. Shock 28 (2007) 504-517
175. Vasina V., Barbara G., Talamonti L., Stanghellini V., Corinaldesi R., Tonini M., et al. Enteric neuroplasticity evoked by inflammation. Auton Neurosci 126-127 (2006) 264-272
176. Venkova K., and Krier J. A nitric oxide and prostaglandin-dependent component of NANC off-contractions in cat colon. Am J Physiol 266 (1994) G40-G47
177. Wallace J.L. COX-2: a pivotal enzyme in mucosal protection and resolution of inflammation. ScientificWorldJournal 6 (2006) 577-588
178. Wallace J.L., and Devchand P.R. Emerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense. Br J Pharmacol 145 (2005) 275-282
179. Waller S.L. Prostaglandins and the gastrointestinal tract. Gut 14 (1973) 402-417
180. Warner T.D., and Mitchell J.A. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J 18 (2004) 790-804
181. Warner T.D., Giuliano F., Vojnovic I., Bukasa A., Mitchell J.A., and Vane J.R. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA 96 (1999) 7563-7568
182. West S.D., Suliburk J.W., Smith G.S., and Mercer D.W. Effects of lipopolysaccharide on gastric stasis: role of cyclooxygenase. Dig Dis Sci 51 (2006) 754-765
183. Wilborn J., DeWitt D.L., and Peters-Golden M. Expression and role of cyclooxygenase isoforms in alveolar and peritoneal macrophages. Am J Physiol 268 (1995) L294-L301
184. 2. Distinct roles of cyclooxygenase-1 and -2. J Biol Chem 272 (1997) 25693-25699
185. Won K.J., Sanders K.M., and Ward S.M. Interstitial cells of Cajal mediate mechanosensitive responses in the stomach. Proc Natl Acad Sci U S A 102 (2005) 14913-14918
186. Wood J.D. Enteric nervous system: reflexes, pattern generators and motility. Curr Opin Gastroenterol 24 (2008) 149-158
187. Xu J., and Chen J.D. Effects of cyclooxygenase-2 inhibitor on glucagon-induced delayed gastric emptying and gastric dysrhythmia in dogs. Neurogastroenterol Motil 19 (2007) 144-151
188. Yildiz T., Koyluoglu G., Bagcivan I., Kaya T., Karadas B., Saraç B., et al. Alterations in spontaneous contractions of rat proximal and distal colon after peritonitis. J Pediatr Surg 42 (2007) 1215-1220
189. Yoneda S., Kito Y., and Suzuki H. Inhibitory actions of indomethacin on electrical and mechanical responses produced by nerve stimulation in circular smooth muscle of the guinea-pig gastric fundus. J Smooth Muscle Res 37 (2001) 81-93